← Leaderboards
Elaine Husni
Cleveland Clinic Lerner Com-Cwru
$877,316
Attributed
$1,754,632
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $354.2K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,754,632 · 1
By mechanism
R01$1,754,632 · 1
Top collaborators
- Unnikrishnan M Chandrasekharan5 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Jagan Ayyappan Pillai$7,065,897
- Serpil C. Erzurum$45,061,611
- Ruth A Keri$12,224,731
- Jaroslaw P Maciejewski$28,244,801
- Jay L Alberts$15,319,411
Others in their field
Other Emerging Leaders on “Genetic Approach”
- Ted Ross · University Of Georgia$59,913,818
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Leonard Freedman · Leidos Biomedical Research, Inc.$42,800,628
- Christopher Barnaby Nelson · University Of Melbourne$26,454,764
- Scott Topper · Broad Institute, Inc.$20,735,000
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
Research focus
Genetic ApproachGenetic PolymorphismAntibodiesAdverse EffectsGenesGenetic MarkersBiobankBiological ProductsBloodArginineAcuteCell Surface ReceptorsBindingChronicClinical DataCultured CellsCytokineDefectEarly TreatmentEpidermisGain Of FunctionGene InductionAdverse EventGenetic Variant
Grant awards (5)
Targeting TNFR2 Pathways in Psoriatic Diseases$354,200
R01 · FY2023 · AR · contact PI
Targeting TNFR2 Pathways in Psoriatic Diseases$350,658
R01 · FY2022 · AR · contact PI
Targeting TNFR2 Pathways in Psoriatic Diseases$343,574
R01 · FY2021 · AR · contact PI
Targeting TNFR2 Pathways in Psoriatic Diseases$354,200
R01 · FY2020 · AR · contact PI
Targeting TNFR2 Pathways in Psoriatic Diseases$352,000
R01 · FY2019 · AR · contact PI